NEW YORK (GenomeWeb News) – Invitrogen and Applied Biosystems today said that European Union regulatory authorities have cleared their proposed $6.7 billion merger.
 
The deal already cleared US antitrust hurdles and is expected to close on Nov. 21, the firms said.
 
ABI stockholders have until the end of the business day on Nov. 19 to elect whether they will receive all cash, all stock, or a mix of the two in consideration for their shares.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.